Ankur Pandya, Ph.D.
Affiliations: | 2012 | Health Policy | Harvard University, Cambridge, MA, United States |
Area:
Public HealthGoogle:
"Ankur Pandya"Cross-listing: PHTree
Parents
Sign in to add mentor| Milton C. Weinstein | grad student | 2012 | Harvard | |
| (Optimizing Cardiovascular Disease Screening and Projection Efforts in the United States.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pei PP, Fitzmaurice KP, Le MH, et al. (2023) The Value-of-Information and Value-of-Implementation from Clinical Trials of Diagnostic Tests for HIV-Associated Tuberculosis: A Modeling Analysis. Mdm Policy & Practice. 8: 23814683231198873 |
| Pandya A, Paulden M, Zhu J, et al. (2022) Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X221097106 |
| Zang X, Mah C, Linh Quan AM, et al. (2021) Human Immunodeficiency Virus transmission by HIV risk group and along the HIV care continuum: A contrast of six US cities. Journal of Acquired Immune Deficiency Syndromes (1999) |
| Quan AML, Mah C, Krebs E, et al. (2021) Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities. The Lancet. Hiv |
| Krebs E, Zang X, Enns B, et al. (2020) Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities. The Journal of Infectious Diseases. 222: S301-S311 |
| Nosyk B, Weiner J, Krebs E, et al. (2020) Dissemination Science to Advance the Use of Simulation Modeling: Our Obligation Moving Forward. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X20945308 |
| Pandya A, Soeteman DI, Gupta A, et al. (2020) Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework? Circulation. Cardiovascular Quality and Outcomes. 13: e006492 |
| Nosyk B, Krebs E, Zang X, et al. (2020) 'Ending the Epidemic' will not happen without addressing racial/ethnic disparities in the US HIV epidemic. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Spahillari A, Zhu J, Ferket BS, et al. (2020) Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals. Jama Cardiology |
| Nosyk B, Zang X, Krebs E, et al. (2020) Ending the HIV epidemic in the USA: an economic modelling study in six cities. The Lancet. Hiv |